Concepedia

Author

Belinda Cancilla

Monash University

Also Known As

B Cancilla, B. Cancilla, Belinda CANCILLA, Belinda Cancilla, Cancilla Belinda

73

Publications

3.7K

Citations

20

H-Index

65

Concepts

All Affiliations

Monash UniversityExelixis (United States)OncoMed (United States)The University of MelbourneMonash Institute of Medical Research
BC

About

Belinda Cancilla is an author at Monash University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

2.6K

2

Health Sciences

2

2

29

3

Natural Sciences

1

1

20

4

Public Health

1

1

37

5

Biochemistry

1

1

20

Belinda Cancilla

×

22

Publications

3.6K

Citations

20

H-Index

YearCitations

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth

F. Michael Yakes, Jason Chen, Jenny Tan,

Molecular Cancer Therapeutics

2011

1.3K

Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer

Jing Shan Lim, Alvaro Ibaseta, Marcus Fischer,

Nature

2017

482

Development of the Zebrafish Lymphatic System Requires Vegfc Signaling

Axel M. Küchler, Evisa Gjini, Josi Peterson-Maduro,

Current Biology

2006

283

Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency

Wan-Ching Yen, Marcus Fischer, Fumiko Axelrod,

Clinical Cancer Research

2015

239

A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of c-Met and Vascular Endothelial Growth Factor Receptor 2

Joseph P. Eder, Geoffrey I. Shapiro, Leonard J. Appleman,

Clinical Cancer Research

2010

191

WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death

Marcus Fischer, Belinda Cancilla, Vincent Yeung,

Science Advances

2017

154

<i>In Vitro</i> and <i>In Vivo</i> Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer

Frauke Bentzien, Marcus Zuzow, Nathan Heald,

Thyroid

2013

129

Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types

Cécile Chartier, Janak Raval, Fumiko Axelrod,

Cancer Research

2016

113

Localization of Activin β<sub>A</sub>-,β<sub>B</sub>-, andβ<sub>C</sub>-Subunits in Human Prostate and Evidence for Formation of New Activin Heterodimers ofβ<sub>C</sub>-Subunit<sup>1</sup>

Sally L. Mellor, Mark Cranfield, Rainer Ries,

The Journal of Clinical Endocrinology & Metabolism

2000

100

Evidence That Estrogens Directly Alter Androgen-Regulated Prostate Development*

Renea A. Jarred, Belinda Cancilla, Gail S. Prins,

Endocrinology

2000

93

Page 1